drugset / Trial / NCT00091468

Nicotine Treatment of Mild Cognitive Impairment (MCI)

NCT00091468

Phase 1 Unknown 75 enrolled National Institute on Aging (NIA)
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this 12-month study is to determine whether nicotine, administered in the form of nicotine patches, can improve symptoms of memory loss in some people experiencing mild memory problems (referred to in this study as "mild cognitive impairment" or MCI).

Timeline

Start
2003-09
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 15 mg Other

Indications